skyglide Explore Beyond
DALLAS — A real-world virtual obesity treatment program that involved use of GLP-1 receptor agonists with intensive lifestyle interventions led to robust and sustained weight loss, according to an analysis of a cohort study. At 12 months, there was an average weight loss of 16.2% of body weight, with results sustained up to 24 months, reported Donna Ryan, MD, of …
Read More »Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Study
